Point72 Asset Management, L.P.
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1603466
STAMFORD, CT
Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,735,577
-$107,053,355 QoQ
Shares Held
46,381
-98.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#105
of 266 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. CRNX ranks #105 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in CRNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,735,577 | 46,381 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $108,788,932 | 2,337,034 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $83,438,819 | 2,003,333 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $57,467,110 | 1,998,161 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,107,468 | 778,398 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $142,598,451 | 2,788,939 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $117,562,857 | 2,300,643 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $124,554,540 | 2,780,856 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $231,685,439 | 4,949,486 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $121,573,302 | 3,416,900 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $125,660,422 | 4,225,300 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $3,635,984 | 226,400 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $24,906,300 | 1,361,000 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $25,732,328 | 1,310,200 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,856,720 | 1,332,800 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $26,479,119 | 1,206,338 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $31,378,163 | 1,104,476 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,468,290 | 449,800 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,348,307 | 708,133 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $19,482,000 | 1,275,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $17,284,792 | 1,225,003 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $8,022,851 | 511,988 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $6,917,456 | 394,832 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||